Federal-State Relations (US) – Page 8

Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market

The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.

By Pam Belluck

Decisions and Verdicts Drugs (Pharmaceuticals) Federal-State Relations (US) Food and Drug Administration mifepristone Regulation and Deregulation of Industry Suits and Litigation (Civil) Supreme Court (US)

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

By Christina Jewett and Pam Belluck

Constitution (US) Courts and the Judiciary Decisions and Verdicts Federal-State Relations (US) Health Insurance and Managed Care Law and Legislation Patient Protection and Affordable Care Act (2010) Preventive Medicine Suits and Litigation (Civil) United States Politics and Government

Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.

A ruling by a federal judge this week could set up yet another Supreme Court challenge to the Obamacare health law.

By Sarah Kliff

Drugs (Pharmaceuticals) Federal-State Relations (US) Food and Drug Administration GenBioPro Law and Legislation Regulation and Deregulation of Industry States (US) Suits and Litigation (Civil)

New Lawsuit Challenges State Bans on Abortion Pills

The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.

By Pam Belluck

mosaec